Skip to main content
    I

    InnovAge Holding Corp (INNV)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $9.58
    +0.11 (+1.16%)

    Market Cap: $1.29B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    InnovAge Holding Corp (INNV) Earnings: Report Dates and Results

    Updated Nov 3, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    InnovAge Holding (INNV) is expected to report earnings on Feb 1, 2027. In the quarter ended Sep 30, 2026, InnovAge Holding reported EPS of $0.14, above the $0.11 estimate. It beat the EPS estimate in 7 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    44%(12/27)
    Avg Surprise
    +7.17%
    Streak
    1 Q

    Upcoming Estimates

    Reports Feb 1, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.09
    Range$0.09 - $0.09
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.090.0%
    60d ago$0.090.0%
    30d ago$0.00n/a
    7d ago$0.10-10.0%
    Current$0.09
    Revenue Consensus
    $261.10M
    Range$260.00M - $262.20M
    2 analysts
    Reports May 3, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$0.13
    Range$0.13 - $0.13
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.130.0%
    60d ago$0.130.0%
    30d ago$0.00n/a
    7d ago$0.130.0%
    Current$0.13
    Revenue Consensus
    $272.30M
    Range$271.00M - $273.60M
    2 analysts

    Next Report

    INNV has an expected report date of Feb 1, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 10.0% below the $0.10 reported for the quarter ended Dec 31, 2025.

    INNV Earnings Call

    The latest INNV earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 27 quarters below that had an estimate, INNV beat 12, missed 14 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $264.76M, up 12.1% from $236.10M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.14$0.11N/A+27.27%Beat+100.0%10 up, 0 downNov 3, 2026$264.76M
    Jun 30, 2026$0.06$0.09$0.09 - $0.09-33.33%MissN/A11 up, 0 downSep 8, 2026$261.95M
    Mar 31, 2026$0.17$0.05$0.05 - $0.05+240.00%Beat+750.0%10 up, 0 downMay 5, 2026$251.94M
    Dec 31, 2025$0.10$0.04$0.04 - $0.04+150.00%BeatN/A10 up, 0 downFeb 3, 2026$239.71M
    Sep 30, 2025$0.07$0.04$0.04 - $0.04+75.00%BeatN/A10 up, 0 downNov 4, 2025$236.10M
    Jun 30, 2025-$0.01-$0.01N/A+24.81%BeatN/A10 up, 0 downSep 9, 2025$221.42M
    Mar 31, 2025$0.02-$0.01N/A+300.00%BeatN/A10 up, 0 downMay 6, 2025$218.14M
    Dec 31, 2024-$0.01-$0.01N/A+13.04%Beat-200.0%N/A0 up, 0 downFeb 4, 2025$209.00M
    Sep 30, 2024-$0.02-$0.01N/A-100.00%MissN/A40 up, 0 downNov 5, 2024$205.14M
    Jun 30, 2024-$0.01-$0.03-$0.04 - -$0.01+66.67%BeatN/A30 up, 0 downSep 10, 2024$199.40M
    Mar 31, 2024-$0.04-$0.03-$0.04 - -$0.03-33.33%MissN/A40 up, 0 downMay 7, 2024$193.07M
    Dec 31, 2023$0.01-$0.02-$0.05 - -$0.02+150.00%BeatN/A40 up, 0 downFeb 6, 2024$188.90M
    Sep 30, 2023-$0.08-$0.04-$0.05 - -$0.02-100.00%MissN/A40 up, 0 downNov 7, 2023$182.49M
    Jun 30, 2023-$0.09-$0.04-$0.06 - -$0.02-125.00%MissN/A40 up, 0 downSep 12, 2023$176.87M
    Mar 31, 2023-$0.05-$0.05-$0.07 - -$0.030.00%In lineN/A40 up, 0 downMay 9, 2023$172.54M
    Dec 31, 2022-$0.07-$0.09-$0.13 - -$0.07+22.22%Beat-275.0%40 up, 0 downFeb 7, 2023$167.46M
    Sep 30, 2022-$0.05-$0.04-$0.05 - -$0.01-25.00%Miss-171.4%40 up, 0 downNov 8, 2022$171.22M
    Jun 30, 2022-$0.09-$0.03-$0.03 - -$0.02-200.00%Miss-280.0%50 up, 0 downSep 13, 2022$172.86M
    Mar 31, 2022-$0.01$0.06-$0.02 - $0.06-116.67%Miss-114.3%50 up, 0 downMay 10, 2022$177.36M
    Dec 31, 2021$0.04$0.07N/A-42.86%MissN/A70 up, 0 downFeb 9, 2022$175.35M
    Sep 30, 2021$0.07$0.05$0.04 - $0.05+40.00%Beat-6.0%6N/ANov 9, 2021$173.07M
    Jun 30, 2021$0.05$0.06$0.05 - $0.08-16.67%MissN/A50 up, 0 downSep 21, 2021$171.62M
    Mar 31, 2021$0.07-$0.07N/A+200.00%Beat+1.0%4N/AMay 10, 2021$156.31M
    Dec 31, 2020-$0.37N/AN/AN/AN/A-633.9%N/AN/AMar 5, 2021$157.31M
    Sep 30, 2020$0.07N/AN/AN/AN/AN/AN/AN/ADec 31, 2020$152.57M
    Jun 30, 2020-$0.16N/AN/AN/AN/AN/AN/AN/ASep 30, 2020$152.49M
    Mar 31, 2020$0.07N/AN/AN/AN/AN/AN/AN/AJun 29, 2020N/A
    Dec 31, 2019$0.07N/AN/AN/AN/AN/AN/AN/AMar 30, 2020$144.77M
    Sep 30, 2019-$0.81-$0.40-$0.53 - -$0.28-102.50%MissN/A2N/ANov 14, 2019$5.75M
    Jun 30, 2019-$0.66-$0.30-$0.42 - -$0.19-120.00%MissN/A2N/AAug 13, 2019$6.85M
    Mar 31, 2019-$0.81-$0.54-$0.54 - -$0.54-50.00%MissN/A1N/AMay 15, 2019$5.36M
    Dec 31, 2018-$0.81-$0.54N/A-50.00%MissN/AN/AN/AMar 22, 2019$4.75M
    Sep 30, 2018-$1.20N/AN/AN/AN/AN/AN/AN/ANov 14, 2018$7.38M
    Jun 30, 2018-$0.94N/AN/AN/AN/AN/AN/AN/AAug 14, 2018$7.31M
    Mar 31, 2018-$1.03N/AN/AN/AN/AN/AN/AN/AMay 14, 2018$4.54M
    Dec 31, 2017-$1.03N/AN/AN/AN/AN/AN/AN/AMar 8, 2018$2.38M
    Sep 30, 2017-$0.86N/AN/AN/AN/AN/AN/AN/ANov 14, 2017$2.22M
    Jun 30, 2017-$0.74N/AN/AN/AN/AN/AN/AN/AAug 14, 2017$2.04M
    Mar 31, 2017-$1.98N/AN/AN/AN/AN/AN/AN/AMay 12, 2017$2.18M
    Dec 31, 2016-$3.02N/AN/AN/AN/AN/AN/AN/AMar 6, 2017$1.69M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Jun 30, 2026 was $0.40, a profit after a loss of $0.02 per share the year before. It was -$10.17 for the year ended Jun 30, 2017, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Jun 30, 2026$0.40N/A
    Jun 30, 2025-$0.02N/A
    Jun 30, 2024-$0.12N/A
    Jun 30, 2023-$0.26-2700.0%
    Jun 30, 2022$0.01N/A
    Jun 30, 2021-$0.18N/A
    Jun 30, 2020-$0.83N/A
    Jun 30, 2019-$3.48N/A
    Jun 30, 2018-$3.86N/A
    Jun 30, 2017-$10.17N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 6,200 words across 7 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20266,1807
    2026Q2Jun 30, 20265,3407
    2026Q1Mar 31, 20264,8537
    2025Q4Dec 31, 20256,0808
    2025Q3Sep 30, 20256,2649
    2025Q2Jun 30, 20256,9798
    2025Q1Mar 31, 20256,1938
    2024Q4Dec 31, 20245,0237

    2026Q3 Earnings Call

    Opening remarks

    Ryan Kubota Head of Investor Relations Thank you, operator. Good afternoon, and thank you all for joining the InnovAge 2026 Fiscal Third Quarter Earnings Call. With me today is Patrick Blair, CEO; and Ben Adams, CFO. Today, after the market closed, we issued an earnings press release containing detailed information on our fiscal third quarter results. You may access the release on the Investor Relations section of our company website, innovage.com. For those listening to the rebroadcast of this call, we remind you that the remarks made herein are as of today, Tuesday, May 5, 2026, and have not been updated subsequent to this call. During our call, we will refer to certain non-GAAP measures. A reconciliation of these measures to the most directly comparable GAAP measures can be found in our earnings press release posted on our website. We will also make statements that are considered forward-looking, including those related to our 2026 fiscal year projections and guidance, future growth prospects and growth strategy, our clinical and operational value initiatives, the effects of recent legislation and federal budget cuts, including Medicare and Medicaid rate pressures, seasonality of cost trends, the status of current and future legal proceedings and regulatory actions and other expectations. Listeners are cautioned that all of our forward-looking statements involve certain assumptions that are inherently subject to risks and uncertainties that can cause our actual results to differ materially from our current expectations. We advise listeners to review the risk factors and other discussions included in our annual report on Form 10-K for fiscal year 2025 and any subsequent reports filed with the SEC, including our most recent quarterly report on Form 10-Q. After the completion of our prepared remarks, we will open the call for questions. I will now turn the call over to our CEO, Patrick Blair. Patrick?

    Patrick Blair Chief Executive Officer Thank you, Ryan, and good afternoon, everyone. I'd like to begin by thanking our InnovAge colleagues, our participants and their families, our government partners and our investor community for your continued trust and support. The work our teams do every day to care for a very complex and vulnerable population is what drives our performance, and I'm proud of the progress we're making and the consistency we're beginning to demonstrate as an organization. We delivered a solid third quarter and continue to see steady momentum across the business. These results reflect stronger operating execution and the benefits of the investments we've made over the past few years to strengthen the platform. For the quarter, we reported approximately $252 million in total revenue, center-level contribution margin of $61 million and adjusted EBITDA of $30 million. We ended the quarter serving approximately 8,050 participants in 6 states across 20 centers.

    Frequently Asked Questions About INNV

    When is InnovAge Holding's next earnings date?

    InnovAge Holding's next earnings report is expected for Feb 1, 2027.

    Did INNV beat earnings estimates last quarter?

    Yes. InnovAge Holding reported EPS of $0.14 for the quarter ended Sep 30, 2026, above the $0.11 estimate, a 27.27% surprise.

    What EPS do analysts expect from INNV next quarter?

    The consensus EPS estimate for InnovAge Holding for the quarter ending Dec 31, 2026 is $0.09 from 1 analyst, with estimates from $0.09 to $0.09.

    How often does INNV beat earnings estimates?

    InnovAge Holding beat the EPS estimate in 7 of the last 8 quarters, with an average surprise of +99.60%.